
Boundless Bio Inc BOLD.O:
BOUNDLESS BIO ANNOUNCES PORTFOLIO PRIORITIZATION AND RUNWAY EXTENSION
BOUNDLESS BIO INC - PRIORITIZES BBI-355/BBI-825 COMBINATION AND BBI-940
BOUNDLESS BIO INC - DISCONTINUES CURRENT ARMS OF BBI-355 IN POTENTIATE TRIAL
BOUNDLESS BIO INC - TO EVALUATE BBI-355/BBI-825 COMBINATION IN 2025
BOUNDLESS BIO INC - REDUCES WORKFORCE BY ONE-THIRD